Myriad Genetics
MYGN
#6699
Rank
ยฃ0.49 B
Marketcap
ยฃ5.32
Share price
-3.27%
Change (1 day)
-55.19%
Change (1 year)

Myriad Genetics (MYGN) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.10 Billion

According to Myriad Genetics's latest financial reports the company has ยฃ0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Myriad Genetics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ81.59 M-26.22%
2023-12-31ยฃ0.11 B16.45%
2022-12-31ยฃ94.97 M-62.16%
2021-12-31ยฃ0.25 B
2020-06-30ยฃ0.17 B63.01%
2019-06-30ยฃ0.10 B-21.13%
2018-06-30ยฃ0.13 B18.01%
2017-06-30ยฃ0.11 B-2.88%
2016-06-30ยฃ0.11 B29.24%
2015-06-30ยฃ92.3 M-15.27%
2014-06-30ยฃ0.10 B-55.51%
2013-06-30ยฃ0.24 B12.81%
2012-06-30ยฃ0.21 B0.54%
2011-06-30ยฃ0.21 B-18.8%
2010-06-30ยฃ0.26 B38.27%
2009-06-30ยฃ0.19 B16.43%
2008-06-30ยฃ0.16 B54.42%
2007-06-30ยฃ0.10 B-14.15%
2006-06-30ยฃ0.12 B93.56%
2005-06-30ยฃ64.35 M1.55%
2004-06-30ยฃ63.37 M43.57%
2003-06-30ยฃ44.14 M-7.42%
2002-06-30ยฃ47.68 M-46.96%
2001-06-30ยฃ89.89 M68.89%
2000-06-30ยฃ53.22 M746.88%
1999-06-30ยฃ6.28 M-28.13%
1998-06-30ยฃ8.74 M-7.26%
1997-06-30ยฃ9.42 M11.05%
1996-06-30ยฃ8.49 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bio-Rad Laboratories
BIO
ยฃ1.06 B 875.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
ยฃ0.75 B 589.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
ยฃ4.97 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.10 B 916.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ5.80 B 5,218.43%๐Ÿ‡บ๐Ÿ‡ธ USA